Agree, it's tricky to value this company based on what's supplied right now - all I could go off is the previously reported NPV's. $400 mil is an acceptable price though, I wouldn't be opposed to seeing that as an offer, but that would be the lower end of the scale in my opinion but not unreasonable.
I also agree that DX will be shaved off, if not used to barter at getting a deal over the line perhaps.
Regardless, as you said Hathorne has put in >$1million of his own money and I doubt he is simply gambling that. He's s seasoned businessman and knows what to expect coming up, as do these new high-net worth investors.
It's just a waiting game now, as always.
- Forums
- ASX - By Stock
- KP2 Discussion
Agree, it's tricky to value this company based on what's...
-
- There are more pages in this discussion • 314 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KP2 (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KP2 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online